He made the field fundable
Dave Gobel co-founded the Methuselah Foundation in 2003, at a point when saying out loud that aging might be addressable was a reliable way to be dismissed. His answer to that was structural rather than rhetorical: prize competitions. If you cannot persuade institutions to fund a field, you can create a target, put money on it, and let people compete to hit it. It worked, and it is a large part of why a generation of researchers had anywhere to go.
The foundation’s practical obsession has been organ availability — tissue engineering, regenerative medicine, the unglamorous business of making sure a body has spare parts. Alongside it sits the Methuselah protocol and an associated clinic delivering it to patients.
He states his mission simply: to reduce the suffering of the world. He is a Christian, and mentions it carefully, aware some viewers may bristle — the instruction he keeps is to do good toward all. And he has a sharp, useful impatience about institutions: he describes having an allergy to foundations that don’t accomplish their mission, the kind that persist comfortably for decades without ever finishing anything.
What struck us most was the family. His son Dane Gobel works alongside him, running the foundation’s prize competitions — including a partnership with NASA — and working with the Biomarker of Aging Consortium. His daughter Danielle, a gerontological nurse practitioner, co-developed the Methuselah protocol with him and delivers it clinically. Her husband Sergio runs business development. We came to Virginia to interview a foundation and found a household that had organised itself around one problem.
